VVUS

VIVUS, Inc. News Headlines

$2.715
*  
0.155
5.4%
Get VVUS Alerts
*Delayed - data as of Mar. 6, 2015 15:08 ET  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VVUS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Cardiovascular Safety Surprise: Wait, Then Buy Orexigen
3/4/2015 8:18:00 AM - Seeking Alpha






Vivus - Flat Qsymia Scripts Point To Needed Shift
3/2/2015 11:25:00 AM - Seeking Alpha


Vivus Sinking With Dwindling Qsymia Market Share
3/2/2015 11:01:00 AM - Seeking Alpha


Orexigen: Contrave Scripts Dip With Sector
3/2/2015 10:36:00 AM - Seeking Alpha
















Orexigen: Contrave Scripts Pass 9,000 - Closing In On Qsymia
2/23/2015 11:00:00 AM - Seeking Alpha




Arena's Belviq Slows At A Bad Time
2/23/2015 9:57:00 AM - Seeking Alpha










Orexigen's Contrave Resumes Solid Growth Rate
2/17/2015 8:45:00 AM - Seeking Alpha


Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
2/8/2015 12:14:00 AM - Seeking Alpha


Vivus' Qsymia Headed In The Wrong Direction
2/7/2015 5:44:00 AM - Seeking Alpha


Orexigen: Contrave Script Sales Dip. Why?
2/6/2015 6:36:00 PM - Seeking Alpha